Select the search type
  • Site
  • Web

Featured Fund

Fund Objective
To achieve capital growth over the medium to long-term period by investing in global markets.
Fund Volatility
Lipper Analytics
10 Apr 2021
Launch Date
30 June 2009
Performance of PWEF vs its Benchmark Index Over the Following Periods Ended 30/04/2021
PWEF (%) Benchmark (%) PWEF (%) Benchmark (%)
Total Return Annualised Return
29.78 26.08 29.78 26.08
36.33 32.00 10.87 9.69
62.22 66.19 10.15 10.68
- - - -
62.22 66.19 10.15 10.68
*Source: Lipper, as at 30 Apr 2021
Performance of PWEF and Benchmark Index (Since Fund Commencement* to 30/04/2021)
Benchmark: A composite of 50% Dow Jones Industrial Average, 30% STOXX Europe 50 Index, 10% TOPIX Core 30 Index and 10% 3-Month Kuala Lumpur Interbank Offered Rate (w.e.f. 30 Apr 2016)
* Commencement Date - 29 April 2016

  • Public Worldwide Equity Fund (PWEF or the Fund) seeks to tap into opportunities in the broader global markets, ranging from established multinationals to emerging high-growth companies.
  • As at 31 March 2021, 87.7% of PWEF’s net asset value (NAV) was invested in equities while 12.3% of NAV was invested in money market instruments. The Fund focused on sectors such as Communications, Technology and Industrial in the U.S., Europe, Korea and Japan.
  • For the 1-year and 3-year periods ended 31 March 2021, the Fund registered respective returns of +37.86% and +38.46% to outperform its benchmark’s respective returns of +33.17% and +33.12%. This outperformance was led by the Fund’s holdings of Technology and Consumer stocks which benefited from the trend of digitalisation as well as the sustained consumer spending on the global front.
  • Going forward, the Fund will look to continue focusing its investments on sectors that offer long-term growth prospects such as Technology, Industrial and Communications, which are underpinned by the continued electronification of products and services. The Fund will also selectively ride on recovery plays within the global and regional markets amid the improved economic prospects following the rollout of Covid-19 vaccines.

Our investment disclaimer can be viewed here.